Skip to main content

Table 4 Individual amino acids, total BCAA, total EAA, and total amino acid concentration maximum (CMax, µmol/L)

From: Bacillus coagulans GBI-30, 6086 improves amino acid absorption from milk protein

Amino Acid

MPC

MPC + BC30

MPC + BC30 vs. MPC

Mean

SD

Mean

SD

p value (t-test)

% Difference

ES (d)

95% CI

Arginine

105

25

121

24

0.008

15.0

0.63

(− 26.9, − 4.5)

Glutamine

688

65

701

81

0.373

1.9

0.18

(− 43.0, 16.6)

Citrulline

43

12

44

8

0.833

0.9

0.04

(− 3.5, 2.8)

Serine

131

21

141

25

0.008

7.8

0.44

(− 17.6, − 2.8)

Asparagine

131

21

106

23

0.561

− 2.8

− 0.12

(− 7.4, 13.4)

Glycine

261

61

277

23

0.049

6.3

0.24

(− 32.8, − 0.04)

Threonine

172

33

177

34

0.476

2.7

0.14

(− 17.7, 8.4)

Alanine

416

99

441

92

0.076

6.2

0.27

(− 54.7, 2.9)

Ornithine

78

16

88

21

0.016

12.6

0.53

(− 17.7, − 2.0)

Methionine

42

7

45

6

0.039

7.1

0.44

(− 5.8, − 0.2)

Proline

314

64

331

56

0.163

5.6

0.29

(− 42.7, 7.5)

Lysine

272

40

288

51

0.056

5.9

0.35

(− 32.5, 0.4)

Aspartic acid

6.3

2.3

7.4

5.2

0.302

17.5

0.27

(− 3.3, 1.1)

Histidine

97

12

98

10

0.348

1.9

0.16

(− 5.6, 2.1)

Valine

462

64

493

101

0.057

6.7

0.37

(− 62.9, 1.0)

Glutamic acid

46

16

54

22

0.021

17.8

0.43

(− 14.9, − 1.3)

Tryptophan

122

25

130

33

0.34

6.0

0.25

(− 22.0, 7.3)

Leucine

275

41

297

62

0.038

8.1

0.42

(− 43.3, − 1.3)

Phenylalanine

89

16

95

13

0.030

7.0

0.42

(− 11.6, − 0.6)

Isoleucine

142

20

154

30

0.042

8.1

0.45

(− 22.6, − 0.4)

Cysteine

21

8

23

9

0.372

9.7

0.23

(− 6.4, 2.5)

Tyrosine

111

18

121

25

0.024

8.8

0.44

(− 18.4, − 1.4)

Total BCAA

882

119

942

186

0.055

6.8

0.38

(− 121, 1.3)

Total EAA

1490

170

1589

248

0.020

6.6

0.47

(− 182, − 17)

Total Amino Acids

3769

775

4042

455

0.003

6.1

0.61

(− 390, − 90)

  1. Data provided is means ± SD. Italic-face font = between-group difference (p < 0.05). CMax = Maximum observed concentration (in μmol/L) for each condition for each participant who completed study trial